Update: 13.02.2023
Last week: 5 week 2023 (30.01.2023 - 05.02.2023)
Last full month: January 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 104 144 | -6.9% | 2.7% | -0.1 | 28 593 926 | -6.4% | 3.4% | -0.2 | -2.0% |
| MoM | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| YTD | 573 078 | -68.5% | 2.8% | -3.4 | 155 211 754 | -55.0% | 3.5% | -2.5 | -29.8% |
| MAT | 8 599 206 | -40.2% | 4.4% | -2.2 | 1 830 380 358 | -27.2% | 4.4% | -1.6 | -10.2% |
| DEXALGIN | |||||||||
| WoW | 15 728 | -21.0% | 0.3% | -0.1 | 8 451 264 | -20.6% | 1.2% | -0.2 | -4.0% |
| MoM | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| YTD | 94 228 | -58.7% | 0.4% | -0.4 | 50 053 963 | -43.5% | 1.4% | -0.9 | -18.4% |
| MAT | 1 451 887 | -23.7% | 0.6% | -0.1 | 648 237 538 | -11.0% | 1.6% | -0.3 | -4.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 50 885 | -2.8% | 38.6% | 1.4 | 32 394 055 | -4.6% | 48.3% | 0.3 | -6.3% |
| MoM | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| YTD | 256 387 | -53.8% | 39.3% | -22.1 | 166 091 589 | -37.0% | 50.1% | -17.9 | -27.8% |
| MAT | 3 985 448 | -25.3% | 50.9% | -14.3 | 2 110 926 875 | -14.6% | 57.1% | -13 | -4.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 653 | -0.5% | 29.9% | -0.7 | 16 092 947 | -2.2% | 47.3% | -1.4 | 1.8% |
| MoM | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| YTD | 101 301 | -38.1% | 29.7% | -9.8 | 79 085 721 | -17.6% | 46.9% | -7.2 | -17.6% |
| MAT | 1 363 834 | -17.5% | 36.0% | -5 | 888 652 631 | -8.3% | 49.6% | -6.1 | -6.0% |
| FASTUM | |||||||||
| WoW | 13 586 | -14.7% | 0.8% | -0.1 | 8 150 636 | -17.2% | 2.2% | -0.5 | -1.8% |
| MoM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| YTD | 75 786 | -48.1% | 0.9% | -0.6 | 46 512 520 | -31.8% | 2.6% | -0.8 | -14.4% |
| MAT | 970 394 | -30.1% | 1.0% | -0.4 | 524 647 033 | -18.6% | 2.4% | -0.7 | -2.1% |
| IODOMARIN | |||||||||
| WoW | 66 021 | 1.2% | 22.4% | 0.9 | 12 308 227 | 1.5% | 9.2% | 0.6 | -2.7% |
| MoM | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| YTD | 296 544 | -20.4% | 21.1% | -1.6 | 54 933 303 | -19.1% | 8.2% | -1.9 | -14.3% |
| MAT | 3 217 468 | -1.7% | 20.4% | -0.6 | 627 019 066 | 3.1% | 8.9% | -0.6 | 1.2% |
| LIOTON | |||||||||
| WoW | 18 382 | 14.5% | 2.0% | 0.3 | 23 059 594 | 11.5% | 5.3% | 0.5 | -1.3% |
| MoM | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| YTD | 70 877 | -47.5% | 1.6% | -0.9 | 88 004 005 | -25.6% | 4.2% | -1.1 | -18.7% |
| MAT | 1 187 599 | -29.9% | 2.1% | -0.6 | 1 277 092 817 | -10.0% | 4.5% | -1.1 | -9.3% |
| MEZYM | |||||||||
| WoW | 197 794 | -10.2% | 19.1% | -0.1 | 31 209 902 | -10.0% | 13.1% | -0.2 | -9.9% |
| MoM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| YTD | 1 102 858 | -54.9% | 19.5% | -11.8 | 171 782 087 | -50.1% | 13.4% | -9.9 | -27.6% |
| MAT | 16 006 991 | -24.9% | 24.2% | -5.3 | 2 471 795 027 | -17.3% | 17.2% | -4.8 | -8.4% |
| MIG 400 | |||||||||
| WoW | 97 480 | -11.4% | 2.1% | -0.2 | 11 865 919 | -15.3% | 1.6% | -0.2 | -4.0% |
| MoM | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| YTD | 541 599 | -43.5% | 2.3% | -1 | 68 878 567 | -37.4% | 1.9% | -0.9 | -18.4% |
| MAT | 7 979 496 | -22.1% | 3.1% | -0.7 | 952 993 103 | -17.8% | 2.4% | -0.7 | -4.3% |
| PROSTAMOL | |||||||||
| WoW | 19 639 | -7.5% | 12.6% | -0.8 | 29 793 754 | -7.0% | 14.4% | -0.7 | -1.3% |
| MoM | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| YTD | 103 193 | -51.1% | 13.6% | -9.7 | 155 151 818 | -44.0% | 15.5% | -9.3 | -16.5% |
| MAT | 1 438 610 | -32.3% | 17.2% | -7.2 | 2 043 123 870 | -24.3% | 18.4% | -8 | -3.8% |
| RESPERO MYRTOL | |||||||||
| WoW | 24 087 | 11.9% | 7.3% | 0.7 | 13 986 191 | 13.8% | 8.8% | 1 | 1.3% |
| MoM | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
| YTD | 116 281 | -40.1% | 7.2% | -2.7 | 66 273 484 | -21.8% | 8.5% | -1.1 | -17.6% |
| MAT | 1 223 806 | 32.6% | 8.0% | 2 | 605 042 006 | 43.7% | 8.3% | 2.1 | -0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 573 078 | -68.5% | 2.8% | -3.4 | 155 211 754 | -55.0% | 3.5% | -2.5 | -29.8% |
| DEXALGIN | 94 228 | -58.7% | 0.4% | -0.4 | 50 053 963 | -43.5% | 1.4% | -0.9 | -18.4% |
| ESPUMISAN (ADULTS) | 256 387 | -53.8% | 39.3% | -22.1 | 166 091 589 | -37.0% | 50.1% | -17.9 | -27.8% |
| ESPUMISAN BABY | 101 301 | -38.1% | 29.7% | -9.8 | 79 085 721 | -17.6% | 46.9% | -7.2 | -17.6% |
| FASTUM | 75 786 | -48.1% | 0.9% | -0.6 | 46 512 520 | -31.8% | 2.6% | -0.8 | -14.4% |
| IODOMARIN | 296 544 | -20.4% | 21.1% | -1.6 | 54 933 303 | -19.1% | 8.2% | -1.9 | -14.3% |
| LIOTON | 70 877 | -47.5% | 1.6% | -0.9 | 88 004 005 | -25.6% | 4.2% | -1.1 | -18.7% |
| MEZYM | 1 102 858 | -54.9% | 19.5% | -11.8 | 171 782 087 | -50.1% | 13.4% | -9.9 | -27.6% |
| MIG 400 | 541 599 | -43.5% | 2.3% | -1 | 68 878 567 | -37.4% | 1.9% | -0.9 | -18.4% |
| PROSTAMOL | 103 193 | -51.1% | 13.6% | -9.7 | 155 151 818 | -44.0% | 15.5% | -9.3 | -16.5% |
| RESPERO MYRTOL | 116 281 | -40.1% | 7.2% | -2.7 | 66 273 484 | -21.8% | 8.5% | -1.1 | -17.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 599 206 | -40.2% | 4.4% | -2.2 | 1 830 380 358 | -27.2% | 4.4% | -1.6 | -10.2% |
| DEXALGIN | 1 451 887 | -23.7% | 0.6% | -0.1 | 648 237 538 | -11.0% | 1.6% | -0.3 | -4.3% |
| ESPUMISAN (ADULTS) | 3 985 448 | -25.3% | 50.9% | -14.3 | 2 110 926 875 | -14.6% | 57.1% | -13 | -4.3% |
| ESPUMISAN BABY | 1 363 834 | -17.5% | 36.0% | -5 | 888 652 631 | -8.3% | 49.6% | -6.1 | -6.0% |
| FASTUM | 970 394 | -30.1% | 1.0% | -0.4 | 524 647 033 | -18.6% | 2.4% | -0.7 | -2.1% |
| IODOMARIN | 3 217 468 | -1.7% | 20.4% | -0.6 | 627 019 066 | 3.1% | 8.9% | -0.6 | 1.2% |
| LIOTON | 1 187 599 | -29.9% | 2.1% | -0.6 | 1 277 092 817 | -10.0% | 4.5% | -1.1 | -9.3% |
| MEZYM | 16 006 991 | -24.9% | 24.2% | -5.3 | 2 471 795 027 | -17.3% | 17.2% | -4.8 | -8.4% |
| MIG 400 | 7 979 496 | -22.1% | 3.1% | -0.7 | 952 993 103 | -17.8% | 2.4% | -0.7 | -4.3% |
| PROSTAMOL | 1 438 610 | -32.3% | 17.2% | -7.2 | 2 043 123 870 | -24.3% | 18.4% | -8 | -3.8% |
| RESPERO MYRTOL | 1 223 806 | 32.6% | 8.0% | 2 | 605 042 006 | 43.7% | 8.3% | 2.1 | -0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 104 144 | -6.9% | 2.7% | -0.1 | 28 593 926 | -6.4% | 3.4% | -0.2 | -2.0% |
| DEXALGIN | 15 728 | -21.0% | 0.3% | -0.1 | 8 451 264 | -20.6% | 1.2% | -0.2 | -4.0% |
| ESPUMISAN (ADULTS) | 50 885 | -2.8% | 38.6% | 1.4 | 32 394 055 | -4.6% | 48.3% | 0.3 | -6.3% |
| ESPUMISAN BABY | 20 653 | -0.5% | 29.9% | -0.7 | 16 092 947 | -2.2% | 47.3% | -1.4 | 1.8% |
| FASTUM | 13 586 | -14.7% | 0.8% | -0.1 | 8 150 636 | -17.2% | 2.2% | -0.5 | -1.8% |
| IODOMARIN | 66 021 | 1.2% | 22.4% | 0.9 | 12 308 227 | 1.5% | 9.2% | 0.6 | -2.7% |
| LIOTON | 18 382 | 14.5% | 2.0% | 0.3 | 23 059 594 | 11.5% | 5.3% | 0.5 | -1.3% |
| MEZYM | 197 794 | -10.2% | 19.1% | -0.1 | 31 209 902 | -10.0% | 13.1% | -0.2 | -9.9% |
| MIG 400 | 97 480 | -11.4% | 2.1% | -0.2 | 11 865 919 | -15.3% | 1.6% | -0.2 | -4.0% |
| PROSTAMOL | 19 639 | -7.5% | 12.6% | -0.8 | 29 793 754 | -7.0% | 14.4% | -0.7 | -1.3% |
| RESPERO MYRTOL | 24 087 | 11.9% | 7.3% | 0.7 | 13 986 191 | 13.8% | 8.8% | 1 | 1.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| DEXALGIN | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| ESPUMISAN (ADULTS) | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| ESPUMISAN BABY | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| FASTUM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| IODOMARIN | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| LIOTON | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| MEZYM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| MIG 400 | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| PROSTAMOL | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| RESPERO MYRTOL | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs